-
(2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-phenyl-1,2-oxazole-4-amido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
-
ChemBase ID:
594
-
Molecular Formular:
C19H19N3O5S
-
Molecular Mass:
401.43626
-
Monoisotopic Mass:
401.10454172
-
SMILES and InChIs
SMILES:
S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)c1c(noc1C)c1ccccc1
Canonical SMILES:
OC(=O)[C@@H]1N2C(=O)[C@H]([C@H]2SC1(C)C)NC(=O)c1c(C)onc1c1ccccc1
InChI:
InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1
InChIKey:
UWYHMGVUTGAWSP-JKIFEVAISA-N
-
Cite this record
CBID:594 http://www.chembase.cn/molecule-594.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-phenyl-1,2-oxazole-4-amido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
|
IUPAC Traditional name
|
(2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-phenyl-1,2-oxazole-4-amido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
|
Brand Name
|
|
Synonyms
|
Oxacillin Sodium
|
Oxacillin
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
3.7509665
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-0.05194399
|
LogD (pH = 7.4)
|
-1.5865542
|
Log P
|
1.697695
|
Molar Refractivity
|
101.8323 cm3
|
Polarizability
|
39.999657 Å3
|
Polar Surface Area
|
112.74 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
Log P
|
2.05
|
LOG S
|
-3.67
|
Solubility (Water)
|
8.62e-02 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Bioassay(PubChem)
Solubility
|
13.9 mg/L
|
Show
data source
|
|
Hydrophobicity(logP)
|
2.4
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
DrugBank -
DB00713
|
Item |
Information |
Drug Groups
|
approved |
Description
|
An antibiotic similar to flucloxacillin used in resistant staphylococci infections. [PubChem] |
Indication |
Used in the treatment of resistant staphylococci infections. |
Pharmacology |
Oxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Oxacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Oxacillin results from the inhibition of cell wall synthesis and is mediated through Oxacillin binding to penicillin binding proteins (PBPs). Oxacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. |
Affected Organisms |
• |
Enteric bacteria and other eubacteria |
|
Half Life |
20 to 30 minutes |
Protein Binding |
94.2 +/- 2.1% (binds to serum protein, mainly albumin) |
Elimination |
Oxacillin Sodium is rapidly excreted as unchanged drug in the urine by glomerular filtration and active tubular secretion. |
External Links |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent